We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Omega Therapeutics Inc | NASDAQ:OMGA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.0128 | -1.56% | 0.8092 | 0.80 | 0.92 | 0.85 | 0.800001 | 0.8034 | 103,154 | 05:00:10 |
From Dec 2023 to Dec 2024
Jefferies Global Healthcare ConferenceDate: Thursday, June 6, 2024Time: 9:30 a.m. ET
Goldman Sachs 45th Annual Global Healthcare ConferenceDate: Monday, June 10, 2024Time: 10:40 a.m. ET
Live webcasts of the fireside chats will be available on the Investors section of the Company's website at www.omegatherapeutics.com. Archived replays will be available on the same website for approximately 90 days.
About Omega TherapeuticsOmega Therapeutics is a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines to treat or cure a broad range of diseases. By pre-transcriptionally modulating gene expression, Omega’s approach enables precision epigenomic control of nearly all human genes, including historically undruggable and difficult-to-treat targets, without altering native nucleic acid sequences. Founded in 2017 by Flagship Pioneering following breakthrough research by world-renowned experts in the field of epigenetics, Omega is led by a seasoned and accomplished leadership team with a track record of innovation and operational excellence. The Company is committed to revolutionizing genomic medicine and has a pipeline of therapeutic candidates derived from its OMEGA platform spanning oncology, regenerative medicine, and multigenic diseases including inflammatory and cardiometabolic conditions.
For more information, visit omegatherapeutics.com, or follow us on X and LinkedIn.
Contact: Eva Stroynowski 617.949.4370 estroynowski@omegatx.com
1 Year Omega Therapeutics Chart |
1 Month Omega Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
